Company Info
| Industry | Biotechnology |
|---|---|
| Sector | Health Technology |
| Employees | 7 |
| CEO | Mr. Michael O'Keefe Sullivan |
| Address | 4902 Eisenhower boulevard Suite 125, Tampa, FL 33634 |
|---|---|
| Phone | 1.813.286.7900 |
| Website | www.oragenics.com |
Oragenics, Inc. is a biopharmaceutical company, which focuses on the development of novel antibiotics and treatments against infectious disease and oral mucositis. Its technology and pipeline is comprised of antibiotics and genetically engineered bacterial strains. The company was founded by Jeffrey D. Hillman and Robert T. Zahradnik in November 1996 and is headquartered in Tampa, FL.
Competitors
| Company Name | 3 Month %Change |
1 Year %Change |
|---|---|---|
| Oragenics, Inc. | -11.85% | 44.73% |
| BellRing Brands, Inc. | -23.22% | 12.37% |
| ImmunoGen, Inc. | -16.49% | -10.38% |
| Heron Therapeutics, Inc. | -18.03% | -48.47% |
| Singular Genomics Systems, Inc. | -32.81% | n/a |
Statement Summary
as of 1:10 ET PM 11/26/2021| Total Assets (MRQ) | 31.1 M |
|---|---|
| Total Liabilities (MRQ) | 2.5 M |
| Shareholders’ Equity (MRQ) | 28.5 M |
| Total Revenue (Annual) | n/a |
| Net Income (Annual) | -4.4 M |
Earnings And Estimates
as of 1:10 ET PM 11/26/2021
| Current Qtr EPS Estimate | -0.04 |
|---|---|
| Current FY EPS Estimate | -0.16 |
| Long Term EPS Growth Estimate | n/a |
| Next Expected Earnings Date | // |
OGEN vs S&P 500
as of 11/26/2021| Relative To S&P 500 |
OGEN | |
|---|---|---|
| 4 Weeks | n/a | n/a |
| 12 Weeks | n/a | n/a |
| YTD | n/a | n/a |
Earnings Surprises
as of 1:10 ET PM 11/26/2021| Fiscal Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 06/2021 | -0.04 | -0.03 | -25.00% |
| 03/2021 | -0.05 | -0.05 | 0.00% |
| 12/2020 | -0.06 | -0.06 | 0.00% |
| 09/2020 | -0.07 | -0.08 | +14.29% |
| 06/2020 | -0.09 | -0.24 | +166.67% |
| 03/2020 | -0.08 | -0.08 | 0.00% |
| 12/2019 | -0.10 | -0.08 | -17.24% |
| 09/2019 | -0.09 | -0.08 | -11.11% |
Financial Strength
as of 1:10 ET PM 11/26/2021| Pre-Tax Margin | 0.00 |
|---|---|
| Net Margin | 0.00 |
| Operating Margin | 0.00 |
| Return On Equity | -93.37 |
| Return On Assets | -84.15 |
| Inventory Turnover (TTM) | 0.00 |
| Sales Growth (MRQ) | n/a |
Ratios
as of 1:10 PM ET 11/26/2021| Price/Earnings (TTM) | n/a |
|---|---|
| Price/Book (MRQ) | 2.47 |
| Price/Cash Flow (TTM) | 0.00 |
| Book Value (MRQ) | 0.22 |
| Quick Ratio (MRQ) | 13.91 |
| Current Ratio (MRQ) | 13.91 |
| Total Debt/Equity (MRQ) | 0.04 |
Short Interest
as of 4:10 PM ET 11/29/2021| % Short - 2.99% | |
| % Remaining Float - 97.01% |
| Current | Last Month | |
|---|---|---|
| Short Interest Date | 11/15/2021 | 10/29/2021 |
| Short Interest Shares | 3,429,556 | 2,812,564 |
| Short Interest Ratio | 0.8 | 0.5 |
M Y M Y
Total Assets 0,0.00 0,0.00
Total Liabilities 0,0.00 0,0.00
Total Equity 0,0.00 0,0.00
M Y M Y
Total Revenue 0,0.00 0,0.00
EBT Exc.
Unusual Items
0,0.00
0,0.00
Net Income 0,0.00 0,0.00
M Y M Y
Cash from
Operations
0,0.00
0,0.00
Cash from
Activities
0,0.00
0,0.00
Cash from
Fin. Activities
0,0.00
0,0.00
TOTAL ASSETS |
TOTAL LIABILITIES |
TOTAL EQUITY |
|---|---|---|
Balance Sheet
| M Y | ||||
|---|---|---|---|---|
| ASSETS | ||||
| Cash And Equivalents | 0,0.00 | |||
| Receivables | 0,0.00 | |||
| Inventories | 0,0.00 | |||
| Other Current Assets | 0,0.00 | |||
| Total Current Assets | 0,0.00 | |||
| Property, Plant & Equipment, Gross | 0,0.00 | |||
| Accumulated Depreciation & Depletion | 0,0.00 | |||
| Property, Plant & Equipment, Net | 0,0.00 | |||
| Intangibles | 0,0.00 | |||
| Other Non-Current Assets | 0,0.00 | |||
| Total Non-Current Assets | 0,0.00 | |||
| TOTAL ASSETS | 0,0.00 | |||
| Liabilities & Shareholder Equity | ||||
| Accounts Payable | 0,0.00 | |||
| Short Term Debt | 0,0.00 | |||
| Total Current Liabilities | 0,0.00 | |||
| Long Term Debt | 0,0.00 | |||
| Deferred Income Taxes | 0,0.00 | |||
| Other Non-Current Liabilities | 0,0.00 | |||
| Minority Interest | 0,0.00 | |||
| Total Non-Current Liabilities | 0,0.00 | |||
| Preferred Stock Equity | 0,0.00 | |||
| Common Stock Equity | 0,0.00 | |||
| Common Par | 0,0.00 | |||
| Additional Paid In Capital | 0,0.00 | |||
| Cumulative Translation Adjustment | 0,0.00 | |||
| Retained Earnings | 0,0.00 | |||
| Treasury Stock | 0,0.00 | |||
| Other Equity Adjustments | 0,0.00 | |||
| Total Capitalization | 0,0.00 | |||
| TOTAL EQUITY | 0,0.00 | |||
| TOTAL LIABILITIES & STOCK EQUITY | 0,0.00 | |||
| Total Common Shares Outstanding | 0,0.00 | |||
| Preferred Shares | 0,0.00 | |||
| Treasury Shares | 0,0.00 | |||
| Basic Weighted Shares Outstanding | 0,0.00 | |||
| Diluted Weighted Shares Outstanding | 0,0.00 | |||
| Number Of Employees | 0,0.00 | |||
| Number Of Part-Time Employees | 0,0.00 | |||
TOTAL REVENUES |
EBT Excluding Unusual Items |
NET INCOME |
|---|---|---|
Income Statement
| M Y | |
|---|---|
| Sales | 0,0.00 |
| Cost Of Sales | 0,0.00 |
| Gross Operating Profit | 0,0.00 |
| Selling, General, And Administrative Expenses | 0,0.00 |
| Research & Development | 0,0.00 |
| Operating Income Before D & A (EBITDA) | 0,0.00 |
| Depreciation & Amortization | 0,0.00 |
| Interest Income | 0,0.00 |
| Other Income - Net | 0,0.00 |
| Special Income / Charges | 0,0.00 |
| Total Income Before Interest Expenses (EBIT) | 0,0.00 |
| Interest Expense | 0,0.00 |
| Pre-Tax Income | 0,0.00 |
| Income Taxes | 0,0.00 |
| Minority Interest | 0,0.00 |
| Net Income From Continuing Operations | 0,0.00 |
| Net Income From Discontinued Operations | 0,0.00 |
| Net Income From Total Operations | 0,0.00 |
| Extraordinary Income/Losses | 0,0.00 |
| Income From Cum. Effect Of Acct. Change | 0,0.00 |
| Income From Tax Loss Carryforward | 0,0.00 |
| Other Gains / Losses | 0,0.00 |
| Total Net Income | 0,0.00 |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
0,0.00 |
| Preferred Dividends | 0,0.00 |
| Net Income Available To Common | 0,0.00 |
| Basic EPS From Continuing Ops. | 0,0.00 |
| Basic EPS From Discontinued Ops. | 0,0.00 |
| Basic EPS From Total Operations | 0,0.00 |
| Basic EPS From Extraordinary Inc. | 0,0.00 |
| Basic EPS From Cum Effect Of Accounting Change | 0,0.00 |
| Basic EPS From Tax Loss Carryf'd. | 0,0.00 |
| Basic EPS From Other Gains (Losses) | 0,0.00 |
| Basic EPS, Total | 0,0.00 |
| Basic Normalized Net Income/Share | 0,0.00 |
| EPS From Continuing Ops. | 0,0.00 |
| EPS From Discontinued Ops | 0,0.00 |
| EPS From Total Ops. | 0,0.00 |
| EPS From Extraord. Inc. | 0,0.00 |
| EPS From Cum Effect of Accounting Change | 0,0.00 |
| EPS From Tax Loss Carfd. | 0,0.00 |
| EPS From Other Gains (L) | 0,0.00 |
| EPS, Total | 0,0.00 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
0,0.00 |
| Dividends Paid Per Share | 0,0.00 |
CASH FROM OPERATIONS |
CASH FROM INVESTING ACTIVITIES |
CASH FROM FINANCING ACTIVITIES |
|---|---|---|
Cash Flow Statement
| M Y | ||||
|---|---|---|---|---|
| Cash Flow From Operating Activities | ||||
| Net Income (Loss) | 0,0.00 | |||
| Operating Gains/Losses | 0,0.00 | |||
| Gross Operating Profit | 0,0.00 | |||
| (Increase) Decrease In Receivables | 0,0.00 | |||
| (Increase) Decrease In Inventories | 0,0.00 | |||
| (Increase) Decrease In Other Current Assets | 0,0.00 | |||
| (Decrease) Increase In Other Current Liabilities | 0,0.00 | |||
| (Increase) Decrease In Other Working Capital | 0,0.00 | |||
| Other Non-Cash Items | 0,0.00 | |||
| Net Cash From Continuing Operations | 0,0.00 | |||
| Net Cash From Discontinued Operations | 0,0.00 | |||
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | 0,0.00 | |||
| Sale Of Property, Plant & Equipment | 0,0.00 | |||
| Cash Used For Investing Activities | ||||
| Sale Of Short-Term Investments | 0,0.00 | |||
| Purchases Of Property, Plant & Equipment | 0,0.00 | |||
| Acquisitions | 0,0.00 | |||
| Purchases Of Short-Term Investments | 0,0.00 | |||
| Other Cash From Investing Activities | 0,0.00 | |||
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | 0,0.00 | |||
| Issuance Of Debt | 0,0.00 | |||
| Cash Used For Financing Activities | ||||
| Issuance Of Capital Stock | 0,0.00 | |||
| Repayment Of Long-Term Debt | 0,0.00 | |||
| Repurchase Of Capital Stock | 0,0.00 | |||
| Payment Of Cash Dividends | 0,0.00 | |||
| Other Financing Charges, Net | 0,0.00 | |||
| Net Cash From Financing Activities | 0,0.00 | |||
| Effect Of Exchange Rate Changes | 0,0.00 | |||
| Net Change In Cash & Cash Equivalents | 0,0.00 | |||
Earnings Estimates
as of 1:10 ET PM 11/26/2021| Current Qtr (09/2021) |
Next Qtr (12/2021) |
|
|---|---|---|
| Consensus Estimate | $-0.04 | $-0.04 |
| # of Estimates | 1 | 1 |
| High Estimate | $-0.04 | $-0.04 |
| Low Estimate | $-0.04 | $-0.04 |
| Year Ago EPS | $-0.03 | $-0.03 |
| Year Over Year Growth Estimate | 21.58% | 21.58% |
| Current Yr (12/2021) |
Next Yr (12/2022) |
|
|---|---|---|
| Consensus Estimate | $-0.16 | $-0.18 |
| # of Estimates | 1 | 1 |
| High Estimate | $-0.16 | $-0.18 |
| Low Estimate | $-0.16 | $-0.18 |
| Year Ago EPS | $-0.47 | $-0.16 |
| Year Over Year Growth Estimate | -65.96% | 12.50% |
| Current Qtr (09/2021) |
Next Qtr (12/2021) |
Current Year (12/2021) |
Next Year (12/2022) |
|
|---|---|---|---|---|
| Consensus Estimate | $-0.04 | $-0.04 | $-0.16 | $-0.18 |
| # of Estimates | 1 | 1 | 1 | 1 |
| High Estimate | $-0.04 | $-0.04 | $-0.16 | $-0.18 |
| Low Estimate | $-0.04 | $-0.04 | $-0.16 | $-0.18 |
| Year Ago EPS | $-0.03 | $-0.03 | $-0.47 | $-0.16 |
| Year Over Year Growth Estimate | 21.58% | 21.58% | -65.96% | 12.50% |
Insider Information Summary
as of 10/31/2021| % Insiders - 1.48% | |
| % Remaining Total Shares - 98.52% |
| Current | 1 Month | |
|---|---|---|
| Net Insider Transaction | 0.00 | 0.00 |
| Shares Bought | 0.00 | 0.00 |
| Shares Sold | 0.00 | 0.00 |
Insider Activity
| Transaction Date | Insider/Title | Transaction Type | Market Value | Shares | Average Price | Current Holdings | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Learn to Trade Like a Pro
Master The Market with the Help of Our Financial Experts
LATEST NEWS
8 Stocks Under $10 Making Big Moves Higher
Nov 13, 2015 9:27 AM EST
Latest News
5 Stocks Poised for Breakouts
Jul 24, 2015 12:13 PM EDT
5 Stocks Under $10 Set to Soar
Jun 11, 2015 11:16 AM EDT
3 Stocks Pushing The Drugs Industry Lower
Mar 10, 2015 4:35 PM EDT
3 Stocks Driving The Health Care Sector Higher
Mar 9, 2015 4:34 PM EDT
3 Stocks Improving Performance Of The Drugs Industry
Mar 9, 2015 4:34 PM EDT
3 Stocks Pushing The Drugs Industry Lower
Mar 3, 2015 3:32 PM EST
3 Drugs Stocks Nudging The Industry Higher
Feb 13, 2015 4:32 PM EST
3 Health Care Stocks Pushing Sector Growth
Feb 10, 2015 4:31 PM EST
3 Stocks Pushing The Drugs Industry Higher
Feb 10, 2015 4:31 PM EST
3 Stocks Pushing The Drugs Industry Lower
Feb 9, 2015 4:32 PM EST
3 Stocks Pushing The Health Care Sector Lower
Feb 4, 2015 4:32 PM EST
3 Stocks Improving Performance Of The Drugs Industry
Jan 30, 2015 4:32 PM EST
3 Stocks Pushing The Health Care Sector Higher
Jan 30, 2015 4:32 PM EST
3 Stocks Advancing The Drugs Industry
Jan 22, 2015 4:32 PM EST
3 Stocks Pushing The Drugs Industry Lower
Nov 19, 2014 3:32 PM EST
3 Stocks Driving The Health Care Sector Higher
Nov 17, 2014 3:32 PM EST
3 Stocks Improving Performance Of The Drugs Industry
Nov 17, 2014 3:32 PM EST
3 Stocks Pushing The Drugs Industry Lower
Oct 29, 2014 4:32 PM EDT
3 Stocks Pushing The Health Care Sector Lower
Oct 22, 2014 4:32 PM EDT
3 Stocks Moving The Drugs Industry Upward
Oct 20, 2014 4:33 PM EDT
3 Drugs Stocks Pushing The Industry Higher
Oct 15, 2014 4:33 PM EDT
3 Health Care Stocks Pushing The Sector Higher
Oct 15, 2014 4:33 PM EDT
3 Stocks Pushing The Health Care Sector Lower
Oct 10, 2014 4:32 PM EDT
3 Stocks Pushing The Drugs Industry Lower
Oct 10, 2014 4:32 PM EDT
Recent Articles from TheStreet
Cramer's Mad Money Recap 11/29: Omicron, Amazon, Netflix
Jim Cramer reminds investors that the Omicron Covid variant doesn't pose systemic risks to the markets.
Lululemon Files Patent Lawsuit Against Peloton
Lululemon seeks injunction in leggings and sports bra design dispute with Peloton.
Jack Dorsey's Net Worth After Twitter Farewell
Twitter's departing CEO has maintained a detached view of his wealth and has donated a lot of it.
Travel Companies Launch Cyber Week Vacation Sales Amid Omicron Woes
Airlines, cruise lines and other travel companies are throwing down Cyber Week deals in the face of new Omicron worries and travel restrictions.
Goldman Reportedly Offers New Benefits to Soothe Workers
Staffers -- particularly young people -- at Goldman and other top investment banks have complained of overwork recently.
Oil Will Hit $125 a Barrel in 2022, $150 in 2023: JPMorgan
OPEC production shortfalls will spark the move, J.P. Morgan says. 'OPEC+ is not immune to the impacts of underinvestment.'
New AWS CEO Hints at Plans to Elevate Amazon's Cloud Computing
Amazon is holding its inaugural re:Invent cloud conference this week.
BioNTech, Pfizer, J&J and Moderna Developing Omicron Vaccines
Pfizer Expects To Have A New Vaccine Ready In Six Weeks
Jim Cramer Talks With Nvidia CEO Jensen Huang
CEO describes a time when every store and drive-through will have an automated avatar -- powered by its chips -- that doesn't make mistakes.
Can Nasdaq, S&P 500 Still Hit New All-Time Highs in 2021?
The stock market is technically in one of its most bullish periods of the year, but after Friday's pullback, investors are worried. Here's how to proceed.